SKYE
Skye Bioscience·NASDAQ
--
--(--)
--
--(--)
3.78 / 10
Netural
Fund-flow analysis shows a good score of 7.56/10, with positive block, small-cap, and extra-large inflows offsetting medium and large negative trends. This robust capital movement supports the idea of underlying interest. Analyst sentiment is overwhelmingly bullish (100% Strong Buy from one analyst), but the historical win rate is 0%, limiting conviction. Overall, the combination of strong fund inflows and bullish ratings is tempered by poor historical performance data, keeping the signal at a neutral level.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-30
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of SKYE?
- SKYE holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.78/10 (Netural).
